bioRxivCancer BiologyPreprint
Multi-modal characterization of transcriptional programs that drive metastatic cascades to solid sites and ascites in ovarian cancer
Kaiyang ZhangiD, Essi KaheliniD, Giovanni MarchiiD, Oskari LehtoneniD, Shams Salloum, Kari LavikkaiD, Yilin LiiD, Felix DietleiniD, Alexandra LahtineniD, Jaana OikkoneniD, Sakari HietaneniD, Johanna HynnineniD, Antti HäkkineniD, Anni VirtaneniD, Sampsa HautaniemiiD
Abstract
Ovarian high-grade serous carcinoma (HGSC) is characterized by extensive intra-peritoneal dissemination and tumor heterogeneity. In the metastatic cascade, tumors utilize several transcriptional programs to translocate and survive in distant tissues. Here, we analyzed multi-modal, real-world data from 350 tumor samples across 160 patients with HGSC to identify transcriptional programs that drive intra-peritoneal metastasis and heterogeneity. We identified nine transcriptional programs, including those regulating epithelial-mesenchymal transition and immune modulation and cytoskeletal reorganization, which shape distinct metastatic trajectories to solid and ascitic environments and are associated to treatment response. Our results reveal pronounced intra-patient transcriptional heterogeneity, which in some cases surpassed inter-patient heterogeneity, highlighting the importance of multi-site sampling for accurate prognostication and combinatorial treatments in HGSC. Our extensive characterization offers novel insights into intra-peritoneal metastasis with significant prognostic implications, reveals histomorphological biomarkers for patient stratification and paves the way for innovative therapeutic strategies aimed at impairing cancer cell adaptability and limiting metastasis.
- organism: human
- assay: bulk RNA-seq
- research focus: clustering
- research focus: differential expression
- research focus: gene regulatory network inference
- approach: statistical model
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Single-cell transcriptomics of heterogeneous patient-derived organoids reveals novel therapeutic targets in high-grade serous ovarian cancer
Bisiayo Fashemi, Yukihide Ota, … Dineo Khabele·bioRxiv·Jun 9, 2026
- Evolutionary states and trajectories characterized by distinct pathways stratify ovarian high-grade serous carcinoma patients
A. Lahtinen, K. Lavikka, … S. Hautaniemi·bioRxiv·Aug 30, 2022
- APOBEC3A drives metastasis of ovarian cancer by altering epithelial-to-mesenchymal transition
Jessica Merritt Devenport, Thi Tran, … Abby M. Green·JCI InsightPeer-reviewed·Mar 9, 2025
- Characterizing intra- and inter-tumor heterogeneity in ovarian high-grade serous carcinoma subtypes using single-cell and spatial transcriptomics
Weishan Li, Laurie Grieshober, … Stephanie C. Hicks·bioRxiv·Sep 15, 2025
- Multi-omic analysis of subtype evolution and heterogeneity in high-grade serous ovarian carcinoma
L. Geistlinger, S. Oh, … L. Waldron·bioRxiv·Jun 12, 2020
- Cancer stem cell transcriptomic signatures reveal patient-to-patient heterogeneity emphasizing the need for patient-specific ovarian cancer targets
Matthew S. Jung, Lindsey J. Davis, … Rachel S. Perkins·bioRxiv·Oct 2, 2026